Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Inovio Pharmaceuticals Inc (INO) Stock: Spiking On Positive Study Results

Inovio Pharmaceuticals Inc (NASDAQ:INO) had an incredibly strong day in the market on Thursday, and for good reason. The company released data with regard to a vaccine that’s proving to be promising. Today, we’ll talk about what we’re seeing from the stock, why, and what we will be watching with regard to INO ahead.

pharmacist, worker, shelves, business, counter, glasses, attractive, medical, competence, chemist, adult, clinic, drugstore, selling, female, consultation, medicine, coat


What We’re Seeing From INO

As mentioned above, Inovio Pharmaceuticals Inc (NASDAQ:INO) had an incredibly strong trading session. After the close of trading, INO is now trading at $7.80 per share after a gain of $0.37 per share or 4.98%.

Why We’re Seeing The Gains

As soon as we noticed that INO was heading up in value at such a pace, the CNA Finance team started to research to see what was behind the uptrend. We believe we’ve found the cause. Early Thursday morning, Inovio Pharmaceuticals released a report with regard to a vaccine it is working on.

In the report, we learned that the vaccine, designed to protect against Zika, has completed a study among non-human primates. In the study, INO found that the Zika vaccine did indeed protect the animals from the infection as well as from brain damage and death! Of course, this is overwhelmingly positive news which caused excitement among investors.

What We’ll Be Watching Ahead

First and foremost, the CNA Finance team plans to keep a close eye on the development of the Zika Vaccine. If INO is able to pull this one together, it could be massive. However, we are watching several things with regard to the stock. At the end of the day, the company has an incredibly strong pipeline, of which the Zika Vaccine is actually a small piece. All in all, we’ll be keeping a close eye on this entire pipeline for a glimpse of what we can expect to see next out of Inovio Pharmaceuticals Inc (NASDAQ:INO) stock.

Follow Inovio Pharmaceuticals Inc. (NASDAQ:INO)
Trade (NASDAQ:INO) Now!

Never Miss The News Again

Do you want real-time, actionable news delivered to your inbox? Join the CNA Finance mailing list below!

Subscribe Today!
* indicates required

Note: This article was written by Joshua Rodriguez, owner and founder of CNA Finance. If you would like to connect with Joshua, you can do so by emailing him at!

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.